Albuminuria testing rates in people with diabetes, Victoria, 2022–2024: analysis of a pathology dataset
Urinary albumin measurement is vital in the screening and monitoring of diabetic kidney disease, but is substantially under-performed. We analysed pathology data from St Vincent's Pathology, Melbourne, between 2022 and 2024 to assess urinary albumin-creatinine ratio (ACR) testing rates in diabetes. Among 19 198 adults, only 23.7% had ≥1 ACR value recorded. Testing increased with risk markers (age, male sex, high hemoglobin A<sub>1c</sub>, low estimated glomerular filtration rate) but remained low, underscoring significant screening and monitoring gaps.
Authors
- Christina Trambas (ORCID: https://orcid.org/0000-0003-2213-642X)
- R. J. MacIsaac
- Samuel F McCormick
- Glenn M Ward
Institutions
- The University of Melbourne (AU)
- St Vincent's Hospital Melbourne (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1111/imj.70348
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00